Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1974 2
1976 1
1977 3
1979 2
1980 2
1981 1
1982 5
1983 8
1984 4
1985 15
1986 4
1987 8
1988 9
1989 12
1990 11
1991 16
1992 24
1993 17
1994 28
1995 13
1996 16
1997 16
1998 15
1999 30
2000 20
2001 28
2002 28
2003 79
2004 61
2005 85
2006 89
2007 123
2008 142
2009 154
2010 168
2011 174
2012 234
2013 209
2014 162
2015 204
2016 200
2017 192
2018 237
2019 254
2020 278
2021 304
2022 328
2023 312
2024 143

Text availability

Article attribute

Article type

Publication date

Search Results

4,068 results

Results by year

Filters applied: . Clear all
Page 1
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Chen HS, Cui Y, Zhou ZH, Zhang H, Wang LX, Wang WZ, Shen LY, Guo LY, Wang EQ, Wang RX, Han J, Dong YL, Li J, Lin YZ, Yang QC, Zhang L, Li JY, Wang J, Xia L, Ma GB, Lu J, Jiang CH, Huang SM, Wan LS, Piao XY, Li Z, Li YS, Yang KH, Wang DL, Nguyen TN; ARAMIS Investigators. Chen HS, et al. Among authors: li jy. JAMA. 2023 Jun 27;329(24):2135-2144. doi: 10.1001/jama.2023.7827. JAMA. 2023. PMID: 37367978 Free PMC article. Clinical Trial.
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment.
Lv J, Wei Y, Yin JH, Chen YP, Zhou GQ, Wei C, Liang XY, Zhang Y, Zhang CJ, He SW, He QM, Huang ZL, Guan JL, Shen JY, Li XM, Li JY, Li WF, Tang LL, Mao YP, Guo R, Sun R, Zheng YH, Zhou WW, Xiong KX, Wang SQ, Jin X, Liu N, Li GB, Kuang DM, Sun Y, Ma J. Lv J, et al. Among authors: li jy. Nat Med. 2023 Jun;29(6):1424-1436. doi: 10.1038/s41591-023-02369-6. Epub 2023 Jun 6. Nat Med. 2023. PMID: 37280275
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study.
Ahn MJ, Kim HR, Yang JCH, Han JY, Li JY, Hochmair MJ, Chang GC, Delmonte A, Lee KH, Campelo RG, Gridelli C, Spira AI, Califano R, Griesinger F, Ghosh S, Felip E, Kim DW, Liu Y, Zhang P, Popat S, Camidge DR. Ahn MJ, et al. Among authors: li jy. Clin Lung Cancer. 2022 Dec;23(8):720-730. doi: 10.1016/j.cllc.2022.07.008. Epub 2022 Jul 21. Clin Lung Cancer. 2022. PMID: 36038416 Free article. Clinical Trial.
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Gui CP, Chen YH, Zhao HW, Cao JZ, Liu TJ, Xiong SW, Yu YF, Liao B, Cao Y, Li JY, Huang KB, Han H, Zhang ZL, Chen WF, Jiang ZY, Gao Y, Han GP, Tang Q, Ouyang K, Qu GM, Wu JT, Guo JP, Li CX, Li PX, Liu ZP, Hsieh JT, Cai MY, Li XS, Wei JH, Luo JH. Gui CP, et al. Among authors: li jy. Lancet Digit Health. 2023 Aug;5(8):e515-e524. doi: 10.1016/S2589-7500(23)00095-X. Epub 2023 Jun 29. Lancet Digit Health. 2023. PMID: 37393162 Free article.
Editorial: Aging and the oocyte.
Luo YY, Huang GN, Li JY. Luo YY, et al. Among authors: li jy. Front Endocrinol (Lausanne). 2024 Jan 16;15:1361115. doi: 10.3389/fendo.2024.1361115. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38298380 Free PMC article. No abstract available.
4,068 results